Form 4 for ALDX Aldeyra Therapeutics, Inc.
Accepted 2023-06-29 00:00:00 ET · period of report 2023-06-27 · accession 0000899243-23-016709 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-29 | 2023-06-27 | ALDX | Bronstein Ben | Dir | M - OptEx | $0.55 | +9,604 | 28.2K | +52% | +$5,282 |
| D | 2023-06-29 | 2023-06-27 | ALDX | Bronstein Ben | Dir | M - OptEx | $0.00 | +9,604 | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-27 | M | A | 9,604 | $0.55 | 28,248 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-06-27 | M | A | 9,604 | $0.00 | 0 | D | $0.55 · — to 2023-09-07 | 9,604 Common Stock | (F1) The stock option is fully vested. |